These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 31544585

  • 1. Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.
    Wang W, Zhang W, Jiang Y, Wang X, Zhang X, Liu H, Zhang T.
    Pharm Dev Technol; 2020 Jan; 25(1):68-75. PubMed ID: 31544585
    [Abstract] [Full Text] [Related]

  • 2. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
    Pi J, Liu Z, Wang H, Gu X, Wang S, Zhang B, Luan H, Zhu Z.
    Curr Drug Deliv; 2016 Jan; 13(8):1358-1366. PubMed ID: 26953239
    [Abstract] [Full Text] [Related]

  • 3. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP, Kushwah V, Katiyar SS, Kumar P, Pillay V, Suresh S, Jain S.
    Int J Pharm; 2017 Dec 20; 534(1-2):1-13. PubMed ID: 28970115
    [Abstract] [Full Text] [Related]

  • 4. Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex.
    Biswas S, Mukherjee PK, Harwansh RK, Bannerjee S, Bhattacharjee P.
    Drug Dev Ind Pharm; 2019 Jun 20; 45(6):946-958. PubMed ID: 30767678
    [Abstract] [Full Text] [Related]

  • 5. Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods.
    Guo B, Liu H, Li Y, Zhao J, Yang D, Wang X, Zhang T.
    Int J Pharm; 2014 Oct 20; 474(1-2):50-6. PubMed ID: 25108049
    [Abstract] [Full Text] [Related]

  • 6. Triple Strategies to Improve Oral Bioavailability by Fabricating Coamorphous Forms of Ursolic Acid with Piperine: Enhancing Water-Solubility, Permeability, and Inhibiting Cytochrome P450 Isozymes.
    Yu D, Kan Z, Shan F, Zang J, Zhou J.
    Mol Pharm; 2020 Dec 07; 17(12):4443-4462. PubMed ID: 32926628
    [Abstract] [Full Text] [Related]

  • 7. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
    Singh C, Bhatt TD, Gill MS, Suresh S.
    Int J Pharm; 2014 Jan 02; 460(1-2):220-7. PubMed ID: 24188983
    [Abstract] [Full Text] [Related]

  • 8. Preparation and evaluation of kaempferol-phospholipid complex for pharmacokinetics and bioavailability in SD rats.
    Zhang K, Gu L, Chen J, Zhang Y, Jiang Y, Zhao L, Bi K, Chen X.
    J Pharm Biomed Anal; 2015 Oct 10; 114():168-75. PubMed ID: 26051640
    [Abstract] [Full Text] [Related]

  • 9. Preparation of a nanoscale dihydromyricetin-phospholipid complex to improve the bioavailability: in vitro and in vivo evaluations.
    Zhao X, Shi C, Zhou X, Lin T, Gong Y, Yin M, Fan L, Wang W, Fang J.
    Eur J Pharm Sci; 2019 Oct 01; 138():104994. PubMed ID: 31302210
    [Abstract] [Full Text] [Related]

  • 10. A phospholipid complex to improve the oral bioavailability of flavonoids.
    Wang H, Cui Y, Fu Q, Deng B, Li G, Yang J, Wu T, Xie Y.
    Drug Dev Ind Pharm; 2015 Oct 01; 41(10):1693-703. PubMed ID: 25496311
    [Abstract] [Full Text] [Related]

  • 11. Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability.
    Qiu L, Zhao X, Zu Y, Zhang Y, Liu Y, Wu W, Li Y.
    Artif Cells Nanomed Biotechnol; 2019 Dec 01; 47(1):610-621. PubMed ID: 30831030
    [Abstract] [Full Text] [Related]

  • 12. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.
    Eur J Drug Metab Pharmacokinet; 2016 Aug 01; 41(4):413-22. PubMed ID: 25669445
    [Abstract] [Full Text] [Related]

  • 13. Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats.
    Mangrulkar S, Shah P, Navnage S, Mazumdar P, Chaple D.
    AAPS PharmSciTech; 2021 Jan 06; 22(1):28. PubMed ID: 33404939
    [Abstract] [Full Text] [Related]

  • 14. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2013 Nov 06; 85(3 Pt B):942-51. PubMed ID: 24075980
    [Abstract] [Full Text] [Related]

  • 15. Melatonin loaded with bacterial cellulose nanofiber by Pickering-emulsion solvent evaporation for enhanced dissolution and bioavailability.
    Li Y, Zhao X, Liu Y, Yang J, Zhang Q, Wang L, Wu W, Yang Q, Liu B.
    Int J Pharm; 2019 Mar 25; 559():393-401. PubMed ID: 30731257
    [Abstract] [Full Text] [Related]

  • 16. Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.
    de Oliveira Eloy J, Saraiva J, de Albuquerque S, Marchetti JM.
    AAPS PharmSciTech; 2012 Dec 25; 13(4):1436-45. PubMed ID: 23070562
    [Abstract] [Full Text] [Related]

  • 17. Preparation and Evaluation of Phospholipid-Based Complex of Standardized Centella Extract (SCE) for the Enhanced Delivery of Phytoconstituents.
    Saoji SD, Raut NA, Dhore PW, Borkar CD, Popielarczyk M, Dave VS.
    AAPS J; 2016 Jan 25; 18(1):102-14. PubMed ID: 26563253
    [Abstract] [Full Text] [Related]

  • 18. Improved oral bioavailability of 20(R)-25-methoxyl-dammarane-3β, 12β, 20-triol using nanoemulsion based on phospholipid complex: design, characterization, and in vivo pharmacokinetics in rats.
    Zhang X, Zhang Y, Guo S, Bai F, Wu T, Zhao Y.
    Drug Des Devel Ther; 2016 Jan 25; 10():3707-3716. PubMed ID: 27877020
    [Abstract] [Full Text] [Related]

  • 19. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
    Yousaf AM, Mustapha O, Kim DW, Kim DS, Kim KS, Jin SG, Yong CS, Youn YS, Oh YK, Kim JO, Choi HG.
    Int J Nanomedicine; 2016 Jan 25; 11():213-21. PubMed ID: 26834471
    [Abstract] [Full Text] [Related]

  • 20. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin.
    Wei Y, Zhou S, Hao T, Zhang J, Gao Y, Qian S.
    Eur J Pharm Sci; 2019 Mar 01; 129():21-30. PubMed ID: 30590119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.